Choudhury, Rawshan
Bayatti, Nadhim
Scharff, Richard
Szula, Ewa
Tilakaratna, Viranga
Udsen, Maja Søberg
McHarg, Selina
Askari, Janet A.
Humphries, Martin J.
Bishop, Paul N.
Clark, Simon J.
Funding for this research was provided by:
Fight for Sight, UK (1852/53)
Macular Society
Medical Research Council (MR/K024418/1)
Helmut Ecker Foundation, Germany
Article History
Received: 4 November 2020
Accepted: 16 June 2021
First Online: 8 July 2021
Competing interests
: PNB, and SJC are inventors of patent applications that describe the use of complement inhibitors for therapeutic purposes, and are co-founders and Directors of Complement Therapeutics, which is developing complement inhibitors for therapeutic purposes. RC, NB, RS, ES, VT, MSU, SM, JAA and MJH all declare that they have no conflicts of interest.